Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 25.11 Million CNY | 86.06% |
| 2022 | 13.49 Million CNY | -68.74% |
| 2021 | 43.17 Million CNY | 52.79% |
| 2020 | 28.26 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 22.87 Million CNY | -8.93% |
| 2024 Q3 | 32.85 Million CNY | 43.14% |
| 2024 Q2 | 22.95 Million CNY | 0.48% |
| 2023 Q1 | 13.4 Million CNY | -0.72% |
| 2023 Q3 | 31.23 Million CNY | 0.5% |
| 2023 Q2 | 31.08 Million CNY | 131.91% |
| 2023 Q4 | 25.11 Million CNY | -19.59% |
| 2023 FY | 25.11 Million CNY | 86.06% |
| 2022 Q3 | 18.24 Million CNY | -0.31% |
| 2022 Q1 | 43.65 Million CNY | 1.1% |
| 2022 FY | 13.49 Million CNY | -68.74% |
| 2022 Q4 | 13.49 Million CNY | -26.0% |
| 2022 Q2 | 18.3 Million CNY | -58.08% |
| 2021 Q3 | 47.63 Million CNY | -0.57% |
| 2021 FY | 43.17 Million CNY | 52.79% |
| 2021 Q4 | 43.17 Million CNY | -9.35% |
| 2021 Q2 | 47.9 Million CNY | -7.35% |
| 2021 Q1 | 51.7 Million CNY | 82.96% |
| 2020 Q4 | 28.26 Million CNY | -5.8% |
| 2020 FY | 28.26 Million CNY | 0.0% |
| 2020 Q2 | 24 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | 30 Million CNY | 25.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |